Table 6. Omalizumab Doses in Milligrams Administered Every 2 to 4 Weeks

Pre-treatment
serum IgE (IU/mL)

Body Weight (kg)
30-60
>60-70
>70-90
>90-150
> 30-100
150 q4 weeks
150 q4 weeks
150 q4 weeks
300 q4 weeks
>100-200
300 q4 weeks
300 q4 weeks
300 q4 weeks
225 q2 weeks
>200-300
300 q4 weeks
225 q2 weeks
225 q2 weeks
300 q2 weeks
>300-400
225 q2 weeks
225 q2 weeks
225 q2 weeks
300 q2 weeks
>400-500
300 q2 weeks
300 q2 weeks
375 q2 weeks
Do Not Use
>500-600
300 q2 weeks
375 q2 weeks
Do Not Use
>600-700
375 q2 weeks
Do Not Use
q=every
Adapted from: Omalizumab package insert. 1 DNA Way, CA:Genentech Inc.; June 2003

Click Here to Return to Article